 |
| The Cytonet Group is an international biotechnology company with locations in Weinheim and Heidelberg in Germany and in Durham, North Carolina in the U.S. The company develops, produces and markets cell therapeutic products, including human liver cells. Cytonet’s goal is to provide alternatives to existing therapies for many diseases with a particular emphasis on liver diseases. Cytonet is a pioneer and leader in the field of regenerative medicine. Through the development of novel approaches to treatment we are helping to shape the future of medicine. ________________________________  |
Fort Worth/ Texas, November 2011 – Giant floral clocks will rise above 28 individuals whose participation as riders aboard Donate Life’s ninth Rose Parade Float will inspire ... read on Weinheim/ Germany, October 2011 –The Canadian health authority, Health Canada, recently granted Cytonet approval to extend the SELICA III trial, which has been open in the United ... read on read on Weinheim, Germany, 1st July 2011 – Dedicated employees, creative inquiry and above all the courage to dare to venture into largely ‘undeveloped ground’ of medicine have brought ... read on
|
 |
|
|
|
|
|
|
